2 Min Read |
An upstart company with a competitor to Allergan Plc’s Botox has its eye on becoming the next wrinkle treatment of choice.
Evolus Inc. has already reached 2,000 doctors with a new app and plans to expand that to 3,000 before the launch of its medicine, Jeuveau, next week. The app includes a 90-day program to start physicians with free samples to encourage…